The content on this site is intended for healthcare professionals only
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid ...
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
14 Apr 2022
PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/...
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
13 Apr 2022
Durvalumab plus chemotherapy significantly improved OS in advanced biliary tract...
Dr Do-Youn Oh - Seoul National University College of Medicine, Seoul, South Kore...
27 Jan 2022
HIMALAYA: Study of tremelimumab and durvalumab as first-line therapy in patients...
Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
27 Jan 2022
OncoAlert Colloquium Day 4: GI oncology and EONS
Dr Cathy Eng, Dr Yelena Janjigian, Ms Stacy Hurt, Ms Allison Rosen, Dr Mark Lewi...
19 Jan 2022
OncoAlert and ecancer weekly round up for October 18th - October 23rd, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
26 Oct 2021
OncoAlert and ecancer weekly round up for October 11th - October 16, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
18 Oct 2021
Radioembolisation with chemotherapy for colorectal liver metastases
Dr Mary Mulcahy - Northwestern Memorial Hospital, Chicago, USA
28 Sep 2021
Pancreatic and Hepatobiliary Cancers
Dr Caio Max Rocha Lima - Wake Forest Baptist Health, North Carolina, USA
28 Jul 2021
Highlights from ASCO 2021
Dr Bishal Gyawali - Queen's University, Kingston, Canada
8 Jun 2021
OncoAlert and ecancer weekly roundup for April 19 - 25, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
26 Apr 2021
Safety and efficacy of atezolizumab plus bevacizumab for unresectable hepatocell...
Prof Richard Finn - Geffen School of Medicine at UCLA, Los Angeles, USA
13 Apr 2021